233712 Marijuana as Medicine: Consider the side effects

Monday, November 8, 2010 : 12:30 PM - 12:50 PM

Tom McLellan, PhD , ONDCP, Washington, DC
  
Dr. McLellan will provide a brief summary about the known medicinal ingredients in cannabis but will go on to discuss the known contraindications at the individual level and at the population level. He will conclude by discussing the policy implications of using public referenda (popular vote) to approve medications. The discussion will be couched in terms of the policies and priorities within the 2010 National Drug Control Strategy.

Learning Areas:
Public health or related public policy
Public health or related research

Learning Objectives:
Attendees at this presentation will be able to describe the legal context of marijuana, the potential implications of legalization on youth use, and summarize the known medicinal ingredients in cannabis. Attendees will also be able to describe how marijuana is addressed in the 2010 National Drug Control Strategy.

Keywords: Marijuana, Policy/Policy Development

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Deputy Director of Office of National Drug Control Policy (ONDCP)
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3184.0: Marijuana and Today’s Youth: Challenges in the face of “medicinal” use and potential legalization